3Firestein, Gray S. Evolving concepts of rheumatoid arthritis.Nature, 2003, 423 : 356 - 361.
4Aupperle KR, Boyle DC, Hendrixx M, et al. Regulation of synoviocyte proliferation, apoptosis, and invasion by the p53 tumor suppressor gene. Am J Pathol, 1998, 152:1091 - 1098.
5Lassus P, Bertrand C, Zugasti O, et al. Anti - apoptotic activity of p53 maps to the COOH - terminal domain and is retained in a highly oncogenic natural mutant. Oncogene, 1999, 18: 4699-4705.
6Micheau O. Cellular FLICE- inhibitory protein: an attractive therapeutic target? Expert Opin Ther Targets, 2003, 4: 559-573.
7Okamoto K, Asahara H, Kobayashi T. Induction of apoptosis in the rheumatoid synovium by Fas ligand gene transfer. Gene Ther, 1998, 5:331 - 338.
8Hoat TM, Hasunuma T, Aono H. Novel mechanisms of selective apoptosis in synovial T cells of patient with rheumatoid arthritis. J Rheumatol, 1996, 23: 1332- 1337.
9Hayashida K, Shimaoka Y, Ochi T, et al. Rheumatoid arthritis synovial stromal cells inhibit apoptosis and up - regulate Bcl -XL expression by B cells in a CD49/CD29 - CD106 - dependent mechanism. J lmmunol, 2001, 164: 1110- 1116.
10Zhang J, Bardos T, MiKecz K, et al. Impaired Fas signaling pathway is involved in defective T cell apoptosis in autoimmune murine arthritis. J Immunol, 2001,166 : 4981 - 4986.
